CurrentEndo coverage · page 7 of 14
Diabetologia
Latest from Diabetologia
Diabetologia
Diabetologia
Diabetologia
Alterations in cerebral perfusion and substrate metabolism in type 2 diabetes: interactions with APOE-ε4
Cross-sectional studyT2D & other
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes
Cross-sectional studyComplications
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia
MAP4K4 aggravates microvascular anomalies in diabetic retinopathy in a YTHDF2-dependent manner
Mechanistic studyComplications
Diabetologia
Diabetologia
Intrapancreatic adipocytes and beta cell dedifferentiation in human type 2 diabetes
Mechanistic studyT2D & other
Diabetologia
Rare MTNR1B variants causing diminished MT2 signalling associate with elevated HbA1c levels but not with type 2 diabetes
Cross-sectional studyT2D & other
Diabetologia
Metformin therapy modifies corneal neuroimmune abnormalities in people with type 2 diabetes
Cross-sectional studyComplications
Diabetologia
Diabetologia
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes affirms markers of disease
Diagnostic or prognostic studyT1D
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Pregnancy and neonatal outcomes in women with GCK-MODY: an observational study based on standardised insulin modalities
Cohort studyDiabetes in pregnancy
Diabetologia
Diabetologia
Continuous glucose monitor metrics from five studies identify participants at risk for type 1 diabetes development
Diagnostic or prognostic studyT1D
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes
Randomized controlled trialT2D & other
Diabetologia
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial
Randomized controlled trialT2D & other
Diabetologia
Diabetologia
Diabetologia
Diabetologia
Diabetologia